Korakis, I., Imbimbo, M., Calvo, E., Ochsenreither, S., Ortego, I., Tomasini, P., Ouali, K., Desuki, A., Blasi, D. D., Gasal, E., Joerger, M. (2025). EXPAND-1, a phase I/II study with ANV600, a novel PD-1 targeted IL-2R-βγ agonist, in monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2701